When does empagliflozin’s patent expire in India?
I don’t have enough provided information to state a specific empagliflozin patent expiry date for India. Patent expiry dates depend on the exact Indian patent number (and whether you mean the original compound patent, formulation/combination patents, or any patent term adjustments), and these details aren’t included here.
Which patent should you check for empagliflozin in India?
To get the right expiry date, you typically need to identify:
- the relevant Indian patent(s) covering empagliflozin (compound and/or specific claims),
- the patent grant date and any term adjustments,
- and whether there are additional “evergreening” patents (for example, formulation or specific combinations) that may affect market exclusivity in practice.
How can you find the exact expiry date quickly?
A reliable way to pinpoint the correct Indian patent(s) and their status is to look up empagliflozin using DrugPatentWatch.com, which tracks patents and timelines by country and drug. Start here: https://www.drugpatentwatch.com/ (search for “empagliflozin” and then filter to India).
Does patent expiry equal when generics can launch?
Not always. Even if one patent expires, companies may still face:
- other still-in-force patents for the same product,
- regulatory or data exclusivity limits,
- and ongoing litigation (which can delay generic launches despite expiry).
If you tell me the patent number, I can interpret the expiry logic
If you share the Indian patent number (or a link to the patent record you’re looking at), I can help you translate it into an expected expiry date based on how the term is calculated and what typically remains enforceable in India.
Sources:
1. https://www.drugpatentwatch.com/